REFERENCES
- Rawicki B, Sheean G, Fung VS, Goldsmith S, Morgan C, Novak I; Cerebral Palsy Institute: Botulinum toxin assessment, intervention and aftercare for paediatric and adult niche indications including pain: international consensus statement. Eur J Neurol 17( Suppl 2): 122–134, 2010.
- Göbel H, Heinze A, Reichel G, Hefter H, Benecke R; Dysport myofascial pain study group: Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study. Pain 125(1–2): 82–88, 2006.
- Wohlfarth K, Sycha T, Ranoux D, Naver H, Caird D: Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment? Curr Med Res Opin 25(7): 1573–1584, 2009.
- Ferrante FM, Bearn L, Rothrock R, King L: Evidence against trigger point injection technique for the treatment of cervicothoracic myofascial pain with botulinum toxin type A. Anesthesiology 103(2): 377–383, 2005.
- Lew HL, Lee EH, Castaneda A, Klima R, Date E: Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study. Arch Phys Med Rehabil 89(1): 75–80, 2008.
- Ojala T, Arokoski JP, Partanen J: The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial. Clin J Pain 22(1): 90–96, 2006.
- Wheeler AH, Goolkasian P, Gretz SS: A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Spine 23(15): 1662–1666; discussion 1667, 1998.
- Wheeler AH, Goolkasian P, Gretz SS: Botulinum toxin A for the treatment of chronic neck pain. Pain 94(3): 255–260, 2001.
- Benecke R, Heinze A, Reichel G, Hefter H, Göbel H; Dysport myofascial pain study group: Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections? Pain Med 12(11): 1607–1614, 2011.